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ABSTRACT. – Assessment of human exposure to toluene diisocyanate. 
Toluene diisocyanate (TDI), an aromatic compound, may be dangerous for human 
health. Diisocyanates have wide industrial use in the fabrication of flexible and 
rigid foams, fibers, elastomers, and coatings such as paints and varnishes. 
Isocyanates are known skin and respiratory sensitizers, and proper engineering 
controls should be in place to prevent exposure to isocyanate liquid and vapor; 
exposure to TDI vapors is well documented to increase asthma risk. The study 
focused on the exposure of workers and nearby populations to toluene 
diisocyanate in a Polyurethane Foam Factory located in Baia Mare, Romania. 
Workplace air measurements were performed in different departments of the plant, 
after sampling either in fixed points or as personal monitoring. Sampling in four 
different locations of Baia Mare town was carried out, - during and after the 
foaming process. TDI sampling was performed on silica cartridge followed by 
GC-MS analysis. TDI concentration at workplace was lower than 0,035 mg/m³, 
which represents the permissible exposure limit, while in the city the TDI 
concentration had shown values below  0,20 ȝg/m³. Health assessment of a group 
of 49 workers was based on questionnaire interview, determination of TDI 
antibodies and lung function tests. Data collected until this stage do not show any 
negative effects of TDI on the employees health. Since this plant had only recently 
begun operating, continuous workplace and ambient air TDI monitoring, along 
with workers health surveillance, is deemed necessary.   
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1.  INTRODUCTION 
 
  Toluene diisocyanate is one of the most common aromatic isocyanates 
used in the production of polyurethane polymers. Polyurethanes are broadly used in 
high resiliency flexible foam seating, rigid foam insulation panels, microcellular 
foam seals and gaskets, durable elastomeric wheels and tires, automotive 
suspension bushings, electrical potting compounds, high performance adhesives 
and sealants, Spandex fibers, seals, gaskets, carpet underlay, and hard plastic parts 
(such as for electronic instruments). The global consumption of polyurethane raw 
materials is climbing, having an average annual growth rate of about 5% (Avar, 
2008); this represents a rising industry, making very important the development of 
safer and less polluting manufacturing methods.   388
  TDI (molecular formula C9-H6-N2-O2) is the most volatile of the isocyanate 
compounds.  In its commonest form TDI is a colorless to pale-yellow liquid 
consisting of a mixture of 2,4- and 2,6-diisocyanates isomers which will 
polymerize readily in air. It has a high vapor pressure (0.025 mmHg at 25 
0C; 
boiling point 115-120 
0C) and must be strictly controlled to prevent fugitive 
emission losses to atmosphere. TDI liquid must be managed carefully as, at 
temperature below 8-14 
0C, the substance will begin to freeze, creating special 
problems in outdoor handling activities for much of the year.  
  Toluene diisocyanate (TDI) is the second highly produced diisocyanate, 
accounting for 34.1% of the global isocyanate market in 2000 (Randall and Lee, 
2002). It is a hazardous aromatic compound synthesized in six steps (Randall and 
Lee, 2002), in which phosgenation of corresponding amines represents the main 
technical process for the manufacture of isocyanates. The amine raw materials are 
generally manufactured by the hydrogenation of corresponding nitro compounds; 
in this case, toluenediamine (TDA) is manufactured from dinitrotoluene, which 
then converted to toluene diisocyanate (TDI).   
  Isocyanates are known skin and respiratory sensitizers, and proper engi-
neering controls should be in place to prevent exposure to isocyanate liquid and 
vapor; exposure to TDI vapors is well documented to increase asthma risk (Allport et 
al., 2003). Occupational asthma and hypersensitivity pneumonitis as a direct result of 
introduction to isocyanates in general and TDI in particular have been extensively 
researched, predominantly in last 10 to 15 years (Ott et al., 2007; Aul et al., 1999). 
Other forms of hypersensitivity manifestation have also been linked to diisocyanates 
and TDI professional contacts (dermatitis – Estlander et al., 1992; eye - conjunctiva, 
mucosal irritation – Omae et al., 1992; Littorin et al., 2007). 
  There is no permissible exposure limit for TDI in the residential areas in 
Romania. For the Foam Factory in Baia Mare the maximum concentration of TDI 
allowed in community atmosphere is 1 μg/m
3 for 30 minutes.   
 
2.  METHODS 
 
2.1. Environmental sampling and data collecting methodology  
 
  TDI sampling was performed both in the community ( Baia Mare) and at 
the workplace, by either  fixed point or personal monitoring technique. Fixed point 
(-ambient sampling) was carried out at breathing level (1.5 m) with a pump – silica 
cartridge device. Air sampling was correlated with duration of the pollutant 
emission. Personal monitoring is a sampling method very efficient for the exposure 
assessment of workers to occupational hazards, as it is a shift measurement timing. 
This method requires workers wearing the ensemble consisting of a personal pump 
device and the silica cartridge.  
  The first step is to collect the environment data correctly. After the 
sampling points are set up, the stand and the auxiliary devices are fixed, the pump 
must be calibrated for the desired flow. The sample is taken on a silica cartridge 
(adsorbent tube). The pump is started and air is crossing the silica cartridge with a  389
known, steady flow (0.25 l/min) for 20-30 minutes. Absorber tube ends are sealed 
and kept cold (4 °C) until analysis.  
Imission measurement of toluene diisocyanate in the community involve 
sampling on a silica gel cartridge in four points inside the city of Baia Mare, sites 
located at different distances from the plant. 
 
 
 
Fig. 1. The TDI sampling ensemble 
 
In these points, measurements were made for three consecutive days, five probes 
for each location being sampled every day. Sampling was performed as it follows: 
during the foaming process  three samples (at the same time) were taken on each 
point, and two more samples, at 4 and 8 hours after the ending of the foaming 
process, were also taken in each point. This operation was repeated during the next 
two days. The sampling time for the first three tests depends on the foaming 
process duration (the time it takes place is divided by three). For the other two 
samples, the sampling time was 30 minutes. The sampling flow rate for toluene  
diisocyanate was 0.25 l/min.  
x  First point is situated on Motorului 8 street, at a distance of approximately 
1000 m from the factory; 
x  The second point is situated on Culturii 8 street, at 2750 m away from the 
factory; 
x  The third point is on the Vasile Lucaciu 126 street, at a distance of 4750 m 
from the factory; 
x  The last point is situated on the Uzinei 3 street, at a distance of 
approximately 7450 m from the factory.  
Inside the factory, two measurements were performed at fixed points in the 
foaming department, at the ends of the plant: the first one next to the mixer in 
which take place the addition of the components and the second one at the end of  390
the plant were foam block is already formed. The sampling time for this 
measurements was 100 minutes at a flow rate of 0.25 l/min. 
  In this department (foaming), a series of personal monitoring were also 
completed. Three workers with the workplace along the plant had worn the 
ensemble formed by personal pump and silica cartridge. These workplaces were 
situated at the beginning of the plant, next to the mixer, at the middle of the 
conveyor belt and at the end of the line. The sampling in this case was during one 
foaming process, with a flow rate of 0.25 l/min.  
  More personal monitoring was made in the cutting area for two 
workplaces. The sampling time was 120 minutes with the flow rate of 0.25 l/min.   
 
2.2.  The analysis methodology  
 
  The purpose of this procedure is to determine TDI air concentration, after 
adsorption and desorption on activated silica gel cartridge. The method described is 
applicable to both industrial isomers (2,4 - and 2,6 - TDI). The principle of this 
method is quantitatively transfer of the sample from the silica gel cartridge in a vial 
followed by extraction of the toluene diisocyanate with methanol. The extract is 
afterwards measured using a mass spectrometry chromatograph (GC-MS Shimadzu 
QP2010). 
  Laboratory analysis is gas chromatography coupled with mass spectrometry 
and begins with preparing the devices and the column according to instructions. 
After this, the calibration curve must be drawn; initially two series of standard 
solutions were prepared with the solvent. The extraction has been made in the 
following concentrations:  40 μg/l; 60 μg/l; 80 μg/; 100 μg/l. The standards were 
measured by recording the chromatogram for each standard solution. The device 
software plots the calibration curves, these being linear curves. Calibration curve 
should be checked no less than at 12 months, and always when using new reactors. 
Reagents utilized in this method are GC-purity methanol and E1 standard TDI 
(Merck supplier). The sample processing is done by breaking the sample cartridge 
in a lidded vial, then adding 2 ml of methanol, followed by one minute stirring in 
order to make the extraction. The extract is filtered and placed in a smaller vial that 
is sent to the GC analysis. Reading the results occurs by measuring the 
chromatogram under specific working method; the amount of TDI (the area in the 
chromatogram) is read from the calibration curve.  
 
2.3.  Health data collection and analysis   
 
  As the monitoring process began right from the opening of the factory, a 
group of presumably unexposed new workers has been initially evaluated 
throughout a health questionnaire, pulmonary function tests, serum TDI antibodies 
and individual polymorphisms, as well. At a 6 months follow up, lung function 
tests and blood sampling were repeated, while the questionnaire was reapplied to 
the subjects. TDI antibodies and individual polymorphisms are not discussed at this 
moment.   391
  Trained interviewers filled in the questionnaires independently. Questions 
were aimed to record respiratory health problems and allergic background in 
specific details. Smoking habits and close contact with pets or other animals, as 
well as home environment, were briefly asked in the questionnaire, while a special 
attention was paid to the work practice – personal protective equipment, and 
exposure control measures such as ventilation and hygiene conditions, along with 
questions on workers’ compliance to safety rules. A matter of interest was the issue 
of previous contacts with polyurethanes, explicitly TDI and other diisocyanates; 
sections of the questionnaires covered information about pre-employments and 
exposure to insulating construction foams or sprayed paints. 
  The lung function tests were performed and their results interpreted by 
occupational healthcare professionals. Standard spirometry parameters were 
pursued and on their bases, the specific diagnostics were set.  
  For final interpretation of the gathered data, the statistical procedure of Chi-
square test was used. Chi-square (noted Ȥ2) is generally considered the statistical 
indicator of differences among proportions (percentages) and it can reduce the 
foregone conclusions emerged from comparing non-homogenous factions. 
 
3.  RESULTS 
 
3.1.  Environmental monitoring  
 
  During 2010, there were four sets of measurements performed for 
determination of airborne TDI concentrations in Baia Mare:  
x  The first measurements took place on 16, 17, 18 February 2010; 
x  The second set of measurements took place on 23, 24, 25 June 2010; 
x  The third set of measurements were made in 08, 09 and 10 September 2010 
x  The last set of measurements took place on 16, 17, 18 November 2010. 
 
Table 1. Results from inside plant measurements 
 
TDI  
concentration 
STEL 
(15 min) 
TWA 
(8 h)   Workplace 
mg/m3  
Long-blocks cutting operator <0.0002  0.14  0.035  Cutting area (individual  
monitoring)  Cutting operator  <0.0002  0.14  0.035 
 
Mixer operator (engineer)  <0.0002  0.14  0.035 
Paper operator  <0.0002  0.14  0.035 
Foaming hall (individual  
monitoring) 
Cutting operator  <0.0002  0.14  0.035 
 
Near mixer tank (beginning of
plant)  <0.0002 0.14  0.035 
Foaming hall (fixed point)
End of plant (emergence of 
foam blocks)  <0.0002 0.14  0.035  392
  Data obtained after analyzing the TDI samples from the factory are 
presented in table 1. The results obtained after analysis of these samples were 
lower than 0.20 μg/m
3 , which represents the detection limit of the device. 
As shown in table 1, the concentrations of TDI from the samples inside the 
factory are very low, lower than the detection limit of the device. This can be 
explained due to advanced technology in manufacturing facilities, which are all 
automated. 
 
3.2 Health status monitoring 
 
  In questionnaire responses, for increased relevance of this analysis, the 
cohort of subjects was divided into three levels of possible exposure at the working 
station, ranging from level I (the most significant) to level III (least potential 
exposure); these subgroups will be identified as “departments” in paragraphs 
below.  
  Table 2 summarizes the frequency of positive answers in three departments 
with diverse levels of assumed exposure. Categories listed below reflect the main 
lines of interest in projected finales.  
 
Table 2. Positive answers percentage in departments 
 
Foaming 
(level I) 
Cutting 
(level II) 
Administrative
(level III)  Total                  Department
                              (%)
   Category  Initial 6 
months  Initial 6 
months  Initial 6 
months  Initial  6 
months 
Diagnosed respiratory 
disease  0.00 0.00 0.00 0.00 0.00 6.67 0.00 2.08 
Respiratory symptoms  4.08 0.00 8.16 6.25 6.12 2.08 18.36 8.33 
Recent respiratory ailment  0.00 2.08 6.12  12.50  4.08 2.08 10.20 16.67 
Hypersensitivity  2.04 0.00 2.04 0.00 2.04 0.00 6.12 0.00 
Allergic symptoms  0.00 2.08 0.00 6.25 0.00 6.21 0.00 14.58 
Smoking habits  12.24 12.50 16.32 16.67 12.24 12.50 40.81 41.67 
Other TDI exposure  22.44 4.16 22.44 4.16 22.44 8.33 67.34 16.67 
Equipment satisfaction  26.53 22.91 36.73 35.41 24.48 31.25 87.75 89.58 
  
The only comparison that holds statistical significance (p  0.05) is that 
between new exposures to diisocyanates in the two time-lines, since drastically 
fewer had occurred in the 6 months interval. Concerning performed lung tests, in 
the group of 44 valid lung function tests, 39 (88.63%) were considered within 
physiological limits while five (11.37%) persons were diagnosed with mild to 
moderate peripheral obstructive ventilatory dysfunction. The mean prevalence of 
obstructive dysfunction is considered to be around 12% in general population 
(Weaver LK et all, 2009; Kogevinas et all, 1999). Further on, we considered 
prevalence of diagnosed disease in our group in relationship to previously  393
mentioned departments, which theoretically signify different levels of potential 
exposure. 4.55 % of the subjects that presented obstructive dysfunction were in the 
first group, 6.82 % were from the “medium exposure” subgroup and none from the 
Administrative section.   
  In order to establish an indication of patterns to be observed in further 
analysis as more data accumulates, we tried to make a direct comparison between 
frequencies of declared respiratory symptoms and objective spirometry results. 
Tables below present this cumulated information.    
 
Table 3. Connection between respiratory symptoms and dysfunction 
 
(%)  Initial 
Respiratory symptoms
6 months 
Respiratory symptoms Obstructive dysfunction 
Total  18.36  8.33 11.37 
I  4.08  0.00 4.55 
II  8.16  6.25 6.82 
III  6.12  2.08 0.00 
  
Differences between first two columns have proved no statistical 
significance, as already stated through total questionnaires investigation; however, 
a fairly strong correlation has been brought forward when initial and follow-up 
declared symptoms were set beside diagnosed obstructive dysfunctions.     
 
Fig. 2. Regression curves 
 
  The second figure shows the simple linear regressions for the aforemen-
tioned factors, pointing out a similar ascendant trend and a better correlation of 
total lifetime responses (initial questionnaire) with the resulted affections. 
Regression equations may be found in the image.     
Nonetheless, as seen from the picture, the parallel is not conforming to the 
arrangement of departments in presumed exposure order; most asserted symptoms 
are in the second group, both initially and at follow-up.  
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4.  DISCUSSIONS AND CONCLUSIONS  
 
The results of all the TDI samples were lower than the detection limit of 
the device (0.20 μg/m
3).  
The health assessment segment of this monitoring was based upon the 
assumption that there are different levels of exposure risk to TDI, in relation to 
specific workplace demands inside the plant. Overall, few resulting correlations in 
health survey parameters had statistical significance, and no association could be 
drawn between these outcomes and the corresponding working place environment 
– the presumed level of risk considering chemical exposure. 
Furthermore, environmental data collected to this point give no additional 
indication as to whether the initial supposition was correct. However, these results 
are not surprising when keeping in mind that this health information is 
intermediary and situated at a very early point in terms of relevance; from a 
physiological point of view, manifestation of premature clinical effects would have 
been unexpected. Moreover, a single set of probes measuring TDI levels inside the 
plant might prove insufficient for a correct and complete estimation of emissions at 
workplace, especially during foaming process, when large quantities of 
diisocyanates are utilized.  
Clinical literature published data sustain the knowledge of serious health 
effects (e.g. lung function tests changes and bronchial asthma) developed in 
association with very low levels of airborne TDI. Considering this fact when taking 
our results into account, we cannot support the presumption that measurements 
below the level of detection accrue in no adverse health effects.   
Future sets of testing, both subject based and environmental measurements, 
will take place for the next three to four years at an estimated frequency of twice a 
year (approximately at six months).    
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